mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.3 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.3 |